207 related articles for article (PubMed ID: 18824306)
1. [Update on the progestin-only contraception].
Madelenat P; Koskas M;
J Gynecol Obstet Biol Reprod (Paris); 2008 Nov; 37(7):637-60. PubMed ID: 18824306
[TBL] [Abstract][Full Text] [Related]
2. [The statement of Polish Gynecological Society experts on oral use of contraceptive 75 microg desogestrel minipill in different clinical cases--state of art in 2008].
Debski R; Kotarski J; Paszkowski T; Pawelczyk L; Skrzypulec V; Tomaszewski J;
Ginekol Pol; 2009 Jan; 80(1):63-75. PubMed ID: 19323063
[TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V
Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975
[TBL] [Abstract][Full Text] [Related]
4. [Current status of estrogen-progestational contraception].
Tabaste JL; Lesourd-Pontonnier F
Rev Fr Gynecol Obstet; 1994; 89(7-9):406-8. PubMed ID: 7973341
[TBL] [Abstract][Full Text] [Related]
5. Progestogen therapies: differences in clinical effects?
Wiegratz I; Kuhl H
Trends Endocrinol Metab; 2004 Aug; 15(6):277-85. PubMed ID: 15358281
[TBL] [Abstract][Full Text] [Related]
6. [Oral contraceptives and breast cancer].
Zoricić D; Ambrozić B; Perić D
Lijec Vjesn; 1998 Dec; 120(12):392-7. PubMed ID: 19658362
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hormonal contraception on bone mineral density].
Trémollières F
Gynecol Obstet Fertil; 2005; 33(7-8):520-5. PubMed ID: 16005661
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
9. Bone health in estrogen-free contraception.
Hadji P; Colli E; Regidor PA
Osteoporos Int; 2019 Dec; 30(12):2391-2400. PubMed ID: 31446440
[TBL] [Abstract][Full Text] [Related]
10. [Rationalizing progestin-only contraception (except IUS with levonorgestrel)].
Jamin C; Madelenat P
Gynecol Obstet Fertil; 2008 May; 36(5):557-62. PubMed ID: 18485786
[TBL] [Abstract][Full Text] [Related]
11. Use of hormonal contraception in adolescents: skeletal health issues.
Tolaymat LL; Kaunitz AM
Curr Opin Obstet Gynecol; 2009 Oct; 21(5):396-401. PubMed ID: 19491681
[TBL] [Abstract][Full Text] [Related]
12. Therapy insight: guidelines for selection of contraception in women with rheumatic diseases.
Sammaritano LR
Nat Clin Pract Rheumatol; 2007 May; 3(5):273-81; quiz 305-6. PubMed ID: 17471246
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of various progestogens on metabolic risk factors for breast cancer.
Campagnoli C; Abbà C; Ambroggio S; Lotano MR; Peris C
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():22-31. PubMed ID: 17943536
[TBL] [Abstract][Full Text] [Related]
14. [Postpartum birth control: state-of-the-art].
Robin G; Massart P; Graizeau F; Guérin du Masgenet B
Gynecol Obstet Fertil; 2008 Jun; 36(6):603-15. PubMed ID: 18550413
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive devices: intravaginal and intrauterine delivery systems.
Benagiano G; Gabelnick H; Farris M
Expert Rev Med Devices; 2008 Sep; 5(5):639-54. PubMed ID: 18803474
[TBL] [Abstract][Full Text] [Related]
16. Hormonal contraception: noncontraceptive benefits and medical contraindications.
Rager KM; Omar HA
Adolesc Med Clin; 2005 Oct; 16(3):539-51. PubMed ID: 16183538
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.
Burkman RT
Am J Manag Care; 2001 Nov; 7(18 Suppl):S571-4. PubMed ID: 11727395
[TBL] [Abstract][Full Text] [Related]
18. The contraceptive implant.
Hohmann H; Creinin MD
Clin Obstet Gynecol; 2007 Dec; 50(4):907-17. PubMed ID: 17982333
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. Hormonal contraception: recent advances and controversies.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S229-35. PubMed ID: 17055831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
